An year back I wrote my first blog about Watson. I have been closely following what’s happening with Watson. Here are some facts on Watson and what user’s of Watson are speaking about it.
Quick Facts About Watson:
- By the end of this year, Watson will touch one billion people in some way
- Watson can “see,” able to describe the contents of an image. For example, Watson can identify melanoma from skin lesion images with 95 percent accuracy, according to research with Memorial Sloan Kettering.
- Watson can “hear,” understanding speech including Japanese, Mandarin, Spanish, Portuguese, among others.
- Watson can “read” 9 languages.
- Watson can “feel” impulses from sensors in elevators, buildings, autos and even ball bearings.
- Watson has been trained on 8 types of cancers, with plans to add 6 more this year.
- Beyond oncology, Watson is in use by nearly half of the top 25 life sciences companies, major manufacturers for IoT applications, retail and financial services firms, and partners like GM, H&R Block and SalesForce.com.
- At IBM, there are more than 1,000 researchers focused solely on artificial intelligence
But perhaps more important than what Watson can do, it is what people, businesses and institutions of all sizes are doing with Watson. See what some IBM Watson users are saying.
“What IBM and Watson has been at the leading edge of is providing enterprise grade, commercially ready cognitive services, fully integrated with a top notch cloud and many other services from analytics to support and sales & marketing.” — André M. König, Co-Founder @ Opentopic Inc. This quote was included in Mr. König’s article “Watson is a Joke?” featured on LinkedIn.
“All of us involved in training Watson… are absolutely convinced that this technology will become an indispensable part of a doctor’s armamentarium to care for patients.” — Mark G. Kris, MD, lead physician of the Memorial Sloan-Kettering-IBM Watson collaboration. Dr. Kris’s quote was featured in a June 25, 2017 article in the American Society of Clinical Oncology entitled “How Watson for Oncology is Advancing Personalized Patient Care.”
“But, the probably more exciting part about it is in 30 percent of patients Watson found something new. And so that’s 300-plus people where Watson identified a treatment that a well-meaning, hard-working group of physicians hadn’t found.” Dr. Norman “Ned” Sharpless, director of the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill and recent presidential appointee as director of the National Cancer Institute.
Dr. Sharpless’ made these comments in a “60 Minutes” segment that aired on October 2016 and again on June 25, 2017. The segment can be viewed here.
“30 minutes is down to 8 minutes to screen a patient…That coordinator can now spend that valuable time gained … in educating the patient on why it’s important for her to be in that clinical trial, helping to break down other barriers.” Dr. Tufia Haddad, MD, Breast Medical Oncologist, Mayo Clinic, made these comments during an AI in Healthcare panel during HIMSS 2017, reported here.
“We could have individually looked at the 1,500 proteins and genes but it would have taken us much longer to do so. IBM Watson for Drug Discovery, with its robust knowledge base, was able to rapidly give us new and novel information we would not otherwise have had.” – Robert Bowser, PhD, director of the Gregory W. Fulton ALS Research Center at Barrow Neurological Institute and one of the nation’s leading ALS researchers. Quote is from a press release announcing the recent Society for Neuroscience study findings.
“[With Watson], we’re seeing some really tremendous efficiencies gained in the drilling business – [including] an 80 percent reduction in the geoscience research time we need to actually design our wells. That means geoscience searchers are doing geoscience not looking out for more data.” -Peter Coleman, CEO and Managing Director for Woodside [source: Investor Briefing, March 7, 2017]
“[Watson services] was a wake-up call for us – that cognitive solutions are real and powerful. We felt that IBM had, by far, the largest lead in terms of where cognitive was going and that the Watson team would be in the best position to help our business users.” -Ryan Bartley, Head of Applied Innovation at Staples [source: IBM Watson blog, February 10, 2017]
“It’s not man versus machine—they very much work hand and hand. Our analysts continue to play a critical role in evaluating a cyber security incident, while Watson for Cyber Security enforces their decisions and validates what they are sharing with the customer at risk. It enables security analysts to deliver faster and more accurate details on a breach, so we may better protect our customers.” – Ronan Murphy, CEO, Smarttech (source: Press Release, May 11, 2017)